Electrophysiology and Arrhythmias

STRENGTH Results

Principal investigator A. Michael Lincoff, MD summarizes the results of the STRENGTH Trial, which looked at the effects of omega-3 carboxylic acid on clinical outcomes in patients at high cardiovascular risk.

Science News

VIDEO: The American Heart Association Response to the COVID-19 Crisis
STRENGTH and OMEMI trial results at #AHA20: No reduction in CV events from omega-3 fatty acids
Fighting fires raises risk for irregular heartbeat
Health Equity and Structural Racism Language Guide (PDF)
Call to Action: Structural Racism as a Fundamental Driver of Health Disparities

Journals

Left Atrial Appendage Thrombus Detected During Hyperacute Stroke Imaging Is Associated With Atrial Fibrillation
Correcting Inappropriate Prescribing of Direct Oral Anticoagulants: A Population Health Approach
Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation
Shortening Ambulance Response Time Increases Survival in Out‐of‐Hospital Cardiac Arrest
Altered Acylcarnitine Metabolism Is Associated With an Increased Risk of Atrial Fibrillation

Continuing Education

Registration Now Open

The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, partners can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


American Heart Association Professional Partners

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses